Security
Moolec Science SA Ordinary Shares · MLEC
MLECNASDAQCommon stockHistorical · closed Nov 2, 2026CIK 1937737Updated Nov 18, 2026
MLEC price & chart
This listing closed Nov 2, 2026. Live provider charts are shown only for current listings.
In the news
No coverage from other publishers is available.
Recent filings
Show 5 more recent filings
Financials
FY 2024 · USDSource
Source
cash flow · annual statements
| Line item | Q4 2023 | Q4 2022 | Q3 2023 | Q2 2025 | Q2 2024 | Q2 2023 | Q1 2024 | Q1 2023 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||
| Profit or LossUSD | — | — | — | -2,427,307Source | -1,783,517Source | — | -1,591,003Source | -721,426Source | -7,312,260Source | -51,788,880Source |
| Additional Financial Items | ||||||||||
| AdjustmentsForDecreaseIncreaseInTradeAccountReceivableUSD | — | — | — | — | — | — | -146,394Source | — | 94,474Source | — |
| AdjustmentsForIncomeTaxExpenseUSD | — | — | — | — | — | — | -215,291Source | — | -1,046,985Source | -234,542Source |
| AdjustmentsForIncreaseDecreaseInTradeAccountPayableUSD | — | — | — | — | — | — | — | — | 2,502,486Source | 1,485,151Source |
| AdjustmentsForSharebasedPaymentsUSD | — | — | — | — | — | — | 407,356Source | — | 2,047,090Source | 1,095,114Source |
| DividendsPaidOrdinarySharesPerShareUSD per share | — | — | — | — | — | — | — | — | 0.05Source | 0.08Source |
| GoodwillUSD | — | — | — | 281,034Source | — | — | 248,273Source | — | 262,532Source | 251,440Source |
| InterestPaidClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | 48,279Source | — | 570,224Source | 24,098Source |
| PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | 13,952Source | — | 105,120Source | — |
| ProceedsFromBorrowingsClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | — | — | 2,591,780Source | — |
| ProceedsFromIssuingSharesUSD | — | — | — | — | — | — | — | — | 2,172,400Source | 10,683Source |
| PurchaseOfIntangibleAssetsClassifiedAsInvestingActivitiesUSD | — | — | — | — | — | — | — | — | — | 164,362Source |
| RepaymentsOfBorrowingsClassifiedAsFinancingActivitiesUSD | — | — | — | — | — | — | 182,976Source | — | 2,512,486Source | 876,769Source |
| GeneralAndAdministrativeExpense | — | — | —Source | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2023 | Q4 2022 | Q3 2023 | Q2 2025 | Q2 2024 | Q2 2023 | Q1 2024 | Q1 2023 | FY 2024 | FY 2023 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cost of Goods and Services Sold | — | — | — | —Source | —Source | — | —Source | — | —Source | —Source |
| Gross Profit (Calculated) · Derived | — | — | — | — | — | — | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | — | — | — | — | — | — | — | 108,282Source |
| Total RevenueUSD | — | — | — | 2,642,964Source | 252,114Source | — | 1,740,050Source | — | 5,625,124Source | 905,049Source |
| Additional Financial Items | ||||||||||
| AdministrativeExpenseUSD | — | — | — | 956,846Source | 1,685,349Source | — | 1,863,418Source | 314,565Source | 7,522,850Source | 4,808,655Source |
| BasicEarningsLossPerShareUSD per share | — | — | — | -0.06Source | -0.05Source | — | -0.04Source | -0.02Source | -0.19Source | -1.5Source |
| DepreciationAndAmortisationExpenseUSD | — | — | — | — | — | — | 36,578Source | — | — | 23,398Source |
| DilutedEarningsLossPerShareUSD per share | — | — | — | -0.06Source | -0.05Source | — | -0.04Source | -0.02Source | -0.19Source | -1.5Source |
| EmployeeBenefitsExpenseUSD | — | — | — | — | — | — | 432,097Source | 42,373Source | — | 1,166,755Source |
| FinanceCostsUSD | — | — | — | 664,020Source | 103,390Source | — | 93,317Source | — | 1,165,418Source | 160,035Source |
| IncomeTaxExpenseContinuingOperationsUSD | — | — | — | 280,889Source | -235,990Source | — | -215,291Source | — | -1,046,985Source | -234,542Source |
| InterestExpenseUSD | — | — | — | 654,611Source | 92,021Source | — | 93,317Source | — | 41,116Source | — |
| InterestExpenseOnLeaseLiabilitiesUSD | — | — | — | 9,409Source | 11,369Source | — | 6,102Source | — | 41,116Source | — |
| OtherIncomeUSD | — | — | — | 36,460Source | 210,856Source | — | — | — | 495,468Source | — |
| OtherOperatingIncomeExpenseUSD | — | — | 906,746Source | -15,427Source | -20,924Source | — | -17,909Source | -11,500Source | -72,717Source | -94,207Source |
| ProfessionalFeesExpenseUSD | — | — | — | — | — | — | — | — | — | 886,628Source |
| ProfitLossBeforeTaxUSD | — | — | -358,579Source | -2,146,418Source | -2,019,507Source | — | -1,806,294Source | -721,426Source | -8,359,245Source | -52,023,422Source |
| ProfitLossFromOperatingActivitiesUSD | — | — | -444,698Source | -2,059,504Source | -1,793,045Source | — | -2,267,915Source | -718,315Source | -9,042,851Source | -6,653,805Source |
| ResearchAndDevelopmentExpenseUSD | — | — | 576,096Source | 298,003Source | 516,022Source | — | 387,736Source | 372,932Source | 1,772,273Source | 1,351,217Source |
| TaxRateEffectOfForeignTaxRatesnumber | — | — | — | — | — | — | — | — | — | 0.1Source |
| ApplicableTaxRate | — | — | — | — | — | — | —Source | —Source | — | — |
| AverageEffectiveTaxRate | — | — | — | — | — | — | —Source | — | — | — |
| GeneralAndAdministrativeExpense | — | — | —Source | — | — | — | — | — | — | — |
| ProfitLossAttributableToOwnersOfParent | — | — | — | — | — | — | — | —Source | — | — |
| ShareOfProfitLossOfAssociatesAndJointVenturesAccountedForUsingEquityMethod | — | — | — | — | — | — | — | — | — | — |
Filing attachments
ea030932701ex99-1.htm · 6-K · 2026-10-21
Exhibit 99.1 October 21, 2026 Securities and Exchange Commission 100 F Street, N.E. Washington, DC 20549 Commissioners: We have read the statements made by Moolec Science SA, pursuant to Item 304(a)(1) of Regulation S-K (copy attached), which we understand will be furnished with the Securities and Exchange Commission on Form 6-K of Moolec Science SA dated October 21, 2026. We agree with the statements concerning our Firm contained therein. Very truly yours, /s/ Price Waterhouse & Co S.R.…
Read attachment ↗ea030801001ex99-1.htm · 6-K · 2026-10-07
Exhibit 99.1 Moolec Science SA (Company number: 421988) c/o Ogier Global (Cayman) Limited,89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands (the “Company”) NOTICE OF AN EXTRAORDINARY GENERAL MEETING OF SHAREHOLDERS Notice An extraordinary general meeting (the “EGM”) of the shareholders of the Company, will be held virtuallyon October 20, 2026, at 9:00 am Eastern Daylight Time (EDT). Moolec Science SA Virtual Extraordinary General Meeting Information : Meeting Date: Tu…
Read attachment ↗ea029061601ex99-1.htm · 6-K · 2026-05-14
Exhibit 99.1 MOOLEC SCIENCE SA MOOLEC SCIENCE SA Unaudited interim condensed consolidated financial statements as of December 31, 2025 and June 30, 2025 and for the six-month periods ended December 31, 2025 and 2024 MOOLEC SCIENCE SA Contents Unaudited interim condensed consolidated financial statements as of December 31, 2025 and June 30, 2025, and for the six-month periods ended December 31, 2025 and 2024. ─────────────────────────────────────────────────────────────────────────────…
Read attachment ↗ea029071101ex99-1.htm · 6-K · 2026-05-13
Exhibit 99.1 Moolec Science SA Regains Compliance with All Nasdaq Capital Market Continued Listing Requirements Within Panel Remediation Period As previously reported on January 29, 2026, Moolec Science SA (“Moolec” and/or the “Company”), received written notice from the Nasdaq Hearings Panel (the “Panel”) informing the Company that the Panel had granted the Company’s request for an extension to regain compliance with the continued listing requirements of The Nasdaq Stock Market LLC, specifica…
Read attachment ↗ea028653901ex99-1.htm · 6-K · 2026-04-15
Exhibit 99.1 Moolec Science SA (Company number: 421988) c/o Ogier Global (Cayman) Limited,89 Nexus Way, Camana Bay, Grand Cayman, KY1-9009, Cayman Islands (the “Company”) NOTICE OF AN ANNUAL GENERAL MEETING OF SHAREHOLDERS 1. Notice An annual general meeting (the “AGM”) of the shareholders of the Company, will be held virtually on May 13, 2026, at 9:00 am (Eastern time). Moolec Science SA Virtual Annual General Meeting Information: Meeting Date: Wednesday, May 13, 2026 Meeting Time: 9:00…
Read attachment ↗ea027493001ex99-1_moolec.htm · 6-K · 2026-01-30
Exhibit 99.1 Moolec Science Granted Continued Listing on Nasdaq subject to Hearings Panel conditions Moolec Science S.A. (“Moolec” or the “Company”), a science-based food ingredient company focused on scalable protein solutions for the global market, today announced that the Nasdaq Hearings Panel (the “Panel”) has granted the Company’s request for continued listing on The Nasdaq Stock Market, subject to certain conditions. The Panel acknowledged that the Company satisfied the minimum bid pric…
Read attachment ↗